GlassScriptPhysician profile
Naga M Komati
NPI 1902014525
$1,152.30
in general payments reported to CMS, 2019-2025
16 companies · $563 in 2025
The $563 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $75.03 · 2021: $244 · 2022: $80.50 · 2023: $17.00 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $223.12 | 2019-2025 | Tavneos |
| Glaxosmithkline, LLC. | $125.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $123.15 | 2025 | Lifevest |
| Mallinckrodt Hospital Products INC. | $105.10 | 2025 | Terlivaz |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2021 | |
| Novo Nordisk INC | $94.87 | 2021 | |
| Travere Therapeutics, INC. | $94.10 | 2025 | |
| Cequr Corporation | $80.50 | 2022 | |
| Janssen Pharmaceuticals, INC | $63.06 | 2020-2021 | |
| Vantive US Healthcare LLC | $30.45 | 2025 | Renal - Pd |
| E.R. Squibb & Sons, L.L.C. | $27.85 | 2020 | |
| Fresenius USA Marketing, INC. | $21.32 | 2019 | |
| Aurinia Pharma U.S., INC. | $19.69 | 2021 | |
| Dexcom, INC. | $17.00 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $13.90 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rockwell Medical, INC. | $13.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naga Komati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.